lncTAC is committed to addressing unmet clinical needs in disease treatment through its exploration of long non-coding RNA (lncRNA). lncTAC has pioneered a proprietary platform technology for extrahepatic delivery of drugs using lncRNA or other natural molecules. The company has engineered targeted delivery modules for diverse tissues and organs, including tumors, skin, and CNS, enabling targeted delivery of therapeutic payloads such as nucleic acid, toxins, radioisotopes, and small molecules, preliminary validation has confirmed the efficacy and safety of our platform
